MedXCell Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.33M
- Investors
-
1
MedXCell General Information
Description
Operator of a healthcare group intended to harness the power of cellular therapies to make lives better. The company is engaged in developing and manufacturing innovative cellular therapies and focuses on technologies, techniques, and novel applications in major diseases such as cancer, autoimmune, neurological, and degenerative disorders, enabling medical practitioners to provide patients with safe treatment for a wide range of their needs.
Contact Information
Website
www.medxcell.chCorporate Office
- Avenue des Planches 20C
- 1820 Montreux
- Switzerland
Corporate Office
- Avenue des Planches 20C
- 1820 Montreux
- Switzerland
MedXCell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A) | 19-Dec-2023 | $2.33M | Completed | Pre-Clinical Trials | ||
| 2. Later Stage VC (Series A) | 04-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 01-Jan-2018 | $1.52M | $1.52M | Completed | Pre-Clinical Trials |
MedXCell Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 2,880,000 | $0.010000 | $0.28 | $0.28 | 1x | $0.28 | 2.68% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MedXCell Comparisons
Industry
Financing
Details
MedXCell Competitors (3)
One of MedXCell’s 3 competitors is Nkarta Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nkarta Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Celularity | Formerly VC-backed | Florham Park, NJ | ||||
| Fate Therapeutics | Formerly VC-backed | San Diego, CA |
MedXCell Patents
MedXCell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023273967-A1 | Trehalose-based surfactants | Pending | 17-May-2022 | ||
| EP-4526313-A1 | Trehalose-based surfactants | Pending | 17-May-2022 | ||
| US-20250304610-A1 | Trehalose-based surfactants | Pending | 17-May-2022 | ||
| WO-2023222659-A1 | Trehalose-based surfactants | Inactive | 17-May-2022 | C07H13/06 |
MedXCell Signals
MedXCell Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Genii Capital | PE/Buyout | Minority |
MedXCell FAQs
-
When was MedXCell founded?
MedXCell was founded in 2016.
-
Where is MedXCell headquartered?
MedXCell is headquartered in Montreux, Switzerland.
-
What is the size of MedXCell?
MedXCell has 13 total employees.
-
What industry is MedXCell in?
MedXCell’s primary industry is Biotechnology.
-
Is MedXCell a private or public company?
MedXCell is a Private company.
-
What is the current valuation of MedXCell?
The current valuation of MedXCell is .
-
What is MedXCell’s current revenue?
The current revenue for MedXCell is .
-
How much funding has MedXCell raised over time?
MedXCell has raised $9.7M.
-
Who are MedXCell’s investors?
Genii Capital has invested in MedXCell.
-
Who are MedXCell’s competitors?
Nkarta Therapeutics, Celularity, and Fate Therapeutics are competitors of MedXCell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process